Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study
Authors:
- M. SuzukiMSM. Suzuki
- S. ArakiSAS. Araki
- T. YamabeTYT. Yamabe
- C. MutoCMC. Muto
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 19 (12) , 1405-1412
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Association of radiographic and symptomatic knee osteoarthritis with health-related quality of life in a population-based cohort study in Japan: the ROAD studyOsteoarthritis and Cartilage, 2010
- Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability studyJournal of Bone and Mineral Metabolism, 2009
- Short‐term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta‐analysis of randomised placebo‐controlled trialsEuropean journal of pain, 2007
- Novel class of pain drugs based on antagonism of NGFTrends in Pharmacological Sciences, 2006
- Risk of Hospitalization for Myocardial Infarction Among Users of Rofecoxib, Celecoxib, and Other NSAIDsArchives of internal medicine (1960), 2005
- Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsBMJ, 2004
- Renal and Related Cardiovascular Effects of Conventional and COX-2-Specific NSAIDs and Non-NSAID AnalgesicsAmerican Journal of Therapeutics, 2000
- NGF as a mediator of inflammatory painPhilosophical Transactions of the Royal Society B: Biological Sciences, 1996
- Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivityNeuroscience, 1994
- Naproxen in osteoarthrosis. Double-blind crossover trial.Annals of the Rheumatic Diseases, 1978